Vyne Therapeutics set for 1-for-50 reverse stock split on July 24

VYNE Therapeutics Inc

VYNE Therapeutics Inc

VYNE

0.00
  • Vyne Therapeutics plans a 1-for-50 reverse stock split effective July 24.
  • Shares are set to trade on a split-adjusted basis on Nasdaq from July 27 under CUSIP 92941V407.
  • The split comes as the company targets an early-week July 27 close for its proposed merger with Yarrow, pending Nasdaq listing clearance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyne Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607231626PRIMZONEFULLFEED9767426) on July 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.